How good is HIV envelope glycoprotein vaccine as a T-lymphocyte stimulant?

How good is HIV envelope glycoprotein vaccine as a T-lymphocyte stimulant?

Bibliographic Details
Main Authors:	Michie, C, Vyakarnam, A, Beverley, P
Format:	Journal article
Language:	English
Published:	1991

Similar Items

Stabilized HIV-1 envelope glycoprotein trimers for vaccine use.
by: Medina-Ramírez, M, et al.
Published: (2017)

Conformational Changes in the HIV/SIV Envelope Glycoprotein
by: Vogan Erik, et al.
Published: (2005-12-01)

HIV-1 Envelope Glycoprotein Trafficking and Viral Transmission
by: Melissa Victoria Fernandez, et al.
Published: (2020-06-01)

The role of the envelope glycoproteins in HIV-1 transmission and pathogenesis
by: Sattentau, Q
Published: (1996)

HIV and SIV Envelope Glycoproteins Interact with Glycolipids and Lipids
by: Rémi Planes, et al.
Published: (2023-07-01)

Apoptosis of uninfected cells induced by HIV envelope glycoproteins
by: Biard-Piechaczyk Martine, et al.
Published: (2004-06-01)

Coevolution Analysis of HIV-1 Envelope Glycoprotein Complex.
by: Reda Rawi, et al.
Published: (2015-01-01)

A Protocol for Studying HIV-1 Envelope Glycoprotein Function
by: Sneha Ratnapriya, et al.
Published: (2020-12-01)

T cell responses to peptides covering the gag p24 region of HIV-1 occur in HIV-1 seronegative individuals.
by: Vyakarnam, A, et al.
Published: (1991)

Structural mechanism of trimeric HIV-1 envelope glycoprotein activation.
by: Erin E H Tran, et al.
Published: (2012-01-01)

Retromer regulates HIV-1 envelope glycoprotein trafficking and incorporation into virions.
by: Elisabetta Groppelli, et al.
Published: (2014-10-01)

Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion
by: Doms Robert W, et al.
Published: (2006-12-01)

Envelope Glycoprotein of Arenaviruses
by: Antonella Pasquato, et al.
Published: (2012-10-01)

STRUCTURAL-ANALYSIS OF THE HIV-1 ENVELOPE GLYCOPROTEIN GP120
by: Moore, J, et al.
Published: (1993)

Correction: Coevolution Analysis of HIV-1 Envelope Glycoprotein Complex.
by: Reda Rawi, et al.
Published: (2015-01-01)

Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens
by: Gregory M. Martin, et al.
Published: (2023-07-01)

Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins.
by: Torben Schiffner, et al.
Published: (2018-05-01)

HIV-1 envelope glycoprotein variable loops are indispensable for envelope structural integrity and virus entry.
by: Tingting Yuan, et al.
Published: (2013-01-01)

Structural plasticity and conformational transitions of HIV envelope glycoprotein gp120.
by: Anil Korkut, et al.
Published: (2012-01-01)

Envelope glycoprotein mobility on HIV-1 particles depends on the virus maturation state
by: Chojnacki, J, et al.
Published: (2017)

Expression-System-Dependent Modulation of HIV-1 Envelope Glycoprotein Antigenicity and Immunogenicity
by: Kong, L, et al.
Published: (2010)

Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity.
by: Kong, L, et al.
Published: (2010)

Global site-specific N-glycosylation analysis of HIV envelope glycoprotein
by: Liwei Cao, et al.
Published: (2017-03-01)

Optimizing the Production of gp145, an HIV-1 Envelope Glycoprotein Vaccine Candidate and Its Encapsulation in Guanosine Microparticles
by: Pearl Akamine, et al.
Published: (2023-05-01)

Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins
by: Schiffner, T, et al.
Published: (2018)

Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression
by: Agustín Valenzuela-Fernández, et al.
Published: (2022-09-01)

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein
by: Jingyou Yu, et al.
Published: (2015-10-01)

HIV-1 Envelope Glycoprotein at the Interface of Host Restriction and Virus Evasion
by: Saina Beitari, et al.
Published: (2019-03-01)

HIV-1 Diversity in the Envelope Glycoproteins: Implications for Viral Entry Inhibition
by: Sabrina E. M. Almeida, et al.
Published: (2013-02-01)

Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptide
by: Sonu Kumar, et al.
Published: (2019-02-01)

Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine
by: Liu Lianxing, et al.
Published: (2010-09-01)

Memory and the lifespan of human T lymphocytes.
by: Beverley, P, et al.
Published: (1993)

Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses
by: Charles J. Russell, et al.
Published: (2021-05-01)

Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles
by: Rosamund Chapman, et al.
Published: (2020-01-01)

A mechanistic understanding of allosteric immune escape pathways in the HIV-1 envelope glycoprotein.
by: Anurag Sethi, et al.
Published: (2013-01-01)

Envelope glycoprotein mobility on HIV-1 particles depends on the virus maturation state
by: Jakub Chojnacki, et al.
Published: (2017-09-01)

Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein.
by: Simon Swingler, et al.
Published: (2007-09-01)

Engineering and characterization of a fluorescent native-like HIV-1 envelope glycoprotein trimer
by: Pritchard, L, et al.
Published: (2015)

A directed molecular evolution approach to improved immunogenicity of the HIV-1 envelope glycoprotein.
by: Sean X Du, et al.
Published: (2011-01-01)

In silico Vaccine Design against Dengue Virus Type 2 Envelope Glycoprotein
by: Muhammad Adnan, et al.
Published: (2020-07-01)